Journal Mobile Options
Table of Contents
36, No. 1-2, 2013
Issue release date: February 2013

Acute Stroke Secondary to Carotid Artery Dissection in a Patient with Germ Cell Tumour: Did Cisplatin Play a Role?

Khadjooi K. · Adab N. · Kenton A.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Cisplatin-based chemotherapy – mainly the bleomycin, etoposide and cisplatin (BEP) regimen – has significantly improved the prognosis of testicular germ cell tumours (GCT). However, it has serious vascular side effects, including acute ischemic stroke. Case Report: A 37-year-old man with no conventional cerebrovascular risk factors presented with right arm clumsiness followed by a transient episode of expressive dysphasia 3 h later. He was receiving the third cycle of BEP for metastatic retroperitoneal GCT. Brain computed tomography (CT) and diffusion-weighted magnetic resonance imaging (MRI) confirmed multiple acute infarctions in the left middle cerebral artery territory. MR angiography and CT angiography showed a dissection with flaps extending into the left internal and external carotid arteries. The patient was anticoagulated and made an almost complete recovery. Conclusion: Carotid artery dissection has not been reported as the cause of cisplatin-associated stroke in patients with GCT. This case demonstrates the potential for cisplatin-induced mechanisms causing carotid dissection, particularly considering the close temporal association of BEP and the event in our patient. In young patients with excellent curative potential from GCT, every effort should be made to minimise the risk of disabling side effects of BEP. After a stroke, imaging of intracranial and extracranial arteries, monitoring and correction of serum magnesium is recommended. The decision to continue or discontinue cisplatin-based chemotherapy should be individualised.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Evans C, Williams M, Mazhar D: Long-term cardiovascular risk following platinum-based chemotherapy for germ cell tumors. Future Oncology 2010;6:365–8.
  2. Dieckmann KP, Gerl A, Witt J, Hartmann JT; German Testicular Cancer Study Group: Myocardial infarction and other major vascular events during chemotherapy for testicular cancer. Ann Oncol 2010;21:1607–11.
  3. Dieckmann K, Gehrckens R: Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma. BMC Cancer 2009; 9:459.
  4. Weijl N, Rutten M, Zwinderman A, Keizer H, Nooy M, Rosendaal F, Cleton F, Osanto S: Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature. J Clin Oncol 2000;18:2169–78.

    External Resources

  5. Etgen T, Weidenhöfer G, Kubin T: Cisplatin-associated occlusion of the internal carotid artery. Onkologie 2009;32:754–7.
  6. Martín GG, Fernández SP, Castro VS, Cueto OH, Acebal MR: Vertebral artery occlusion after chemotherapy. Stroke 2008;39:e38.
  7. Meattini I, Scotti V, Pescini F, Livi L, Sulprizio S, Palumbo V, Sarti C, Biti G: Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature. J Chemother 2010;22:134–6.

    External Resources

  8. Gemmete JJ: Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. J Vasc_ Interv Radiol 2003;14:743–8.
  9. Ghosh N, Chow C, Korley V, Chisholm R: An unusual case of chronic coronary artery dissection: did cisplatin play a role? Can J Cardiol 2008;24: 795–7.
  10. Thanvi B, Munshi SK, Dawson SL, Robinson TG: Carotid and vertebral artery dissection syndromes. Postgrad Med J 2005;81:383–8.
  11. Montiel M, Urso L, de la Blanca EP, Marsigliante S, Jiménez E: Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metallo-proteinase activity. Cell Physiol Biochem 2009;23: 441–8.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00